Literature DB >> 7495275

Pathology and emerging infections--quo vadimus?

D A Schwartz1, R T Bryan, J M Hughes.   

Abstract

There have been dramatic changes in the occurrence of infectious diseases throughout the world in the previous two decades. The emergence of new microbial agents, and the reemergence of infections previously believed to be controlled, threatens the health of all populations. The emergence of these infectious diseases has occurred during a period of breakdown in the capabilities of the public health surveillance systems, prevention programs, and disease control efforts. Expertise in pathology is critical to provide a strong national control program for emerging and reemerging infectious diseases. Despite the many significant achievements made by pathologists in improving understanding of the pathogenesis and diagnosis of infectious diseases, the field of pathology remains largely oriented toward neoplastic diseases, and has not yet identified infectious disease diagnosis as an important component of anatomic pathology training and research, even in the face of the current threats posed by microbial agents. In addition, there is currently a dearth of infectious disease pathologists in the United States and elsewhere in the world, and the use of the autopsy, a prime pathological tool for diagnosis of emerging infections, is on the wane. The most serious problem is that no formal training program for infectious disease pathology currently exists in the United States or elsewhere in the world. As a consequence of this lack of training opportunities, there is a severe deficiency of young, well-educated pathologists with infectious disease expertise. This article explores the historical linkages between the disciplines of infectious diseases and pathology, and suggests that infectious disease pathology as a subspecialty be strengthened and training programs be initiated.

Entities:  

Mesh:

Year:  1995        PMID: 7495275      PMCID: PMC1869939     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  Whipple's disease; observations on systemic involvement. II. Gross and histologic observations.

Authors:  J C SIERACKI; G FINE
Journal:  AMA Arch Pathol       Date:  1959-01

2.  Pathologists request autopsy revival.

Authors:  C Marwick
Journal:  JAMA       Date:  1995-06-28       Impact factor: 56.272

3.  Cat scratch disease: a bacterial infection.

Authors:  D J Wear; A M Margileth; T L Hadfield; G W Fischer; C J Schlagel; F M King
Journal:  Science       Date:  1983-09-30       Impact factor: 47.728

4.  Infectious disease surveillance: a crumbling foundation.

Authors:  R L Berkelman; R T Bryan; M T Osterholm; J W LeDuc; J M Hughes
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

5.  A microsporidian previously undescribed in humans, infecting enterocytes and macrophages, and associated with diarrhea in an acquired immunodeficiency syndrome patient.

Authors:  J M Orenstein; M Tenner; A Cali; D P Kotler
Journal:  Hum Pathol       Date:  1992-07       Impact factor: 3.466

6.  Pathology of symptomatic microsporidial (Encephalitozoon hellem) bronchiolitis in the acquired immunodeficiency syndrome: a new respiratory pathogen diagnosed from lung biopsy, bronchoalveolar lavage, sputum, and tissue culture.

Authors:  D A Schwartz; G S Visvesvara; G J Leitch; L Tashjian; M Pollack; J Holden; R T Bryan
Journal:  Hum Pathol       Date:  1993-09       Impact factor: 3.466

7.  Nocardiosis in HIV-positive patients: an autopsy study in West Africa.

Authors:  S B Lucas; A Hounnou; C Peacock; A Beaumel; A Kadio; K M De Cock
Journal:  Tuber Lung Dis       Date:  1994-08

Review 8.  Emerging infectious diseases in the United States, Improved surveillance, a requisite for prevention.

Authors:  R T Bryan; R W Pinner; R L Berkelman
Journal:  Ann N Y Acad Sci       Date:  1994-12-15       Impact factor: 5.691

9.  Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease.

Authors:  S R Zaki; P W Greer; L M Coffield; C S Goldsmith; K B Nolte; K Foucar; R M Feddersen; R E Zumwalt; G L Miller; A S Khan
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

10.  The mortality and pathology of HIV infection in a west African city.

Authors:  S B Lucas; A Hounnou; C Peacock; A Beaumel; G Djomand; J M N'Gbichi; K Yeboue; M Hondé; M Diomande; C Giordano
Journal:  AIDS       Date:  1993-12       Impact factor: 4.177

View more
  6 in total

1.  Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis.

Authors:  Kum Thong Wong; Wun-Ju Shieh; Shalini Kumar; Karim Norain; Wahidah Abdullah; Jeannette Guarner; Cynthia S Goldsmith; Kaw Bing Chua; Sai Kit Lam; Chong Tin Tan; Khean Jin Goh; Heng Thay Chong; Rani Jusoh; Pierre E Rollin; Thomas G Ksiazek; Sherif R Zaki
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Pathology of infectious diseases: what does the future hold?

Authors:  Paul Hofman; Sebastian Lucas; Grégory Jouvion; Arnault Tauziède-Espariat; Fabrice Chrétien; Gieri Cathomas
Journal:  Virchows Arch       Date:  2017-02-10       Impact factor: 4.064

3.  Barriers to Creutzfeldt-Jakob disease autopsies, California.

Authors:  Kurt B Nolte
Journal:  Emerg Infect Dis       Date:  2005-05       Impact factor: 6.883

Review 4.  Viral infection, proliferation, and hyperplasia of Hofbauer cells and absence of inflammation characterize the placental pathology of fetuses with congenital Zika virus infection.

Authors:  David A Schwartz
Journal:  Arch Gynecol Obstet       Date:  2017-04-11       Impact factor: 2.344

5.  Pathology of infectious diseases: new agents, opportunistic, neglectable, emergent, reemergent diseases and why not super resistant nosocomial bacteria?

Authors:  Amaro Nunes Duarte-Neto
Journal:  Autops Case Rep       Date:  2019-09-27

Review 6.  [What place and what future for the pathology of infectious and tropical diseases in France?].

Authors:  Paul Hofman
Journal:  Ann Pathol       Date:  2014-05-20       Impact factor: 0.407

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.